Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Canadian Bioinformatics Workshops www.bioinformatics.ca Module #: Title of Module 2 Module 5 Metabolomic Data Analysis Using MetaboAnalyst David Wishart Learning Objectives • To become familiar with the standard metabolomics data analysis workflow • To become aware of key elements such as: data integrity checking, outlier detection, quality control, normalization, scaling, etc. • To learn how to use MetaboAnalyst to facilitate data analysis A Typical Metabolomics Experiment 2 Routes to Metabolomics ppm 7 6 5 4 Quantitative (Targeted) Methods 3 2 Chemometric (Profiling) Methods 25 TMAO hippurate allantoin creatinine taurine 1 PC2 20 creatinine 15 10 citrate ANIT 5 hippurate urea 2-oxoglutarate water succinate fumarate 0 -5 -10 ppm 7 6 5 4 3 2 1 Control -15 PAP -20 -25 -30 PC1 -20 -10 0 10 Metabolomics Data Workflow Chemometric Methods Targeted Methods • Data Integrity Check • Spectral alignment or binning • Data normalization • Data QC/outlier removal • Data reduction & analysis • Compound ID • Data Integrity Check • Compound ID and quantification • Data normalization • Data QC/outlier removal • Data reduction & analysis Data Integrity/Quality • LC-MS and GC-MS have high number of false positive peaks • Problems with adducts (LC), extra derivatization products (GC), isotopes, breakdown products (ionization issues), etc. • Not usually a problem with NMR • Check using replicates and adduct calculators MZedDB http://maltese.dbs.aber.ac.uk:8888/hrmet/index.html HMDB http://www.hmdb.ca/search/spectra?type=ms_search Data/Spectral Alignment • Important for LC-MS and GC-MS studies • Not so important for NMR (pH variation) • Many programs available (XCMS, ChromA, Mzmine) • Most based on time warping algorithms http://mzmine.sourceforge.net/ http://bibiserv.techfak.uni-bielefeld.de/chroma http://metlin.scripps.edu/xcms/ Binning (3000 pts to 14 bins) xi,yi x = 232.1 (AOC) y = 10 (bin #) bin1 bin2 bin3 bin4 bin5 bin6 bin7 bin8... Data Normalization/Scaling • Can scale to sample or scale to feature • Scaling to whole sample controls for dilution • Normalize to integrated area, probabilistic quotient method, internal standard, sample specific (weight or volume of sample) • Choice depends on sample & circumstances Same or different? Data Normalization/Scaling • Can scale to sample or scale to feature • Scaling to feature(s) helps manage outliers • Several feature scaling options available: log transformation, autoscaling, Pareto scaling, probabilistic quotient, and range scaling MetaboAnalyst http://www.metaboanalyst.ca Dieterle F et al. Anal Chem. 2006 Jul 1;78(13):4281-90. Data QC, Outlier Removal & Data Reduction • Data filtering (remove solvent peaks, noise filtering, false positives, outlier removal -- needs justification) • Dimensional reduction or feature selection to reduce number of features or factors to consider (PCA or PLS-DA) • Clustering to find similarity MetaboAnalyst http://www.metaboanalyst.ca A comprehensive web server designed to process & analyze LC-MS, GC-MS or NMR-based metabolomic data MetaboAnalyst History • 2009 v1.0 - Supports both univariate and multivariate data processing, including ttests, ANOVA, PCA, PLS-DA, colorful plots, with detailed explanations & summaries • 2012 v2.0 - Identifies significantly altered functions & pathways • 2015 v3.0 – Better performance, better graphical interactivity, biomarker analysis, power analysis, integration with gene expression data … MetaboAnalyst Overview • • • • • Raw data processing Data reduction & statistical analysis Functional enrichment analysis Metabolic pathway analysis Power analysis and sample size estimation • Biomarker analysis • Integrative analysis MetaboAnalyst Modules Data preprocessing Data normalization Data analysis Data interpretation 17 MetaboAnalyst Modules Example Datasets Example Datasets Metabolomic Data Processing Common Tasks • Purpose: to convert various raw data forms into data matrices suitable for statistical analysis • Supported data formats – Concentration tables (Targeted Analysis) – Peak lists (Untargeted) – Spectral bins (Untargeted) – Raw spectra (Untargeted) Select a Module (Statistical Analysis) Data Upload Alternatively … Data Set Selected • Here we have selected a data set from dairy cattle fed different proportions of cereal grains (0%, 15%, 30%, 45%) • The rumen was analyzed using NMR spectroscopy using quantitative metabolomic techniques • High grain diets are thought to be stressful on cows Data Integrity Check Data Normalization Samples = rows Compounds = columns Data Normalization • At this point, the data has been transformed to a matrix with the samples in rows and the variables (compounds/peaks/bins) in columns • MetaboAnalyst offers three types of normalization, row-wise normalization, column-wise normalization and combined normalization • Row-wise normalization aims to make each sample (row) comparable to each other (i.e. urine samples with different dilution effects) Data Normalization • Column-wise normalization aims to make each variable (column) comparable in scale to each other, thereby generating a “normal” distribution • This procedure is useful when variables are of very different orders of magnitude • Four methods have been implemented for this purpose – log transformation, autoscaling, Pareto scaling and range scaling Normalization Result Data Normalization • You cannot know a priori what the best normalization protocol will be • MetaboAnalyst allows you to interactively explore different normalization protocols and to visually inspect the degree of “normality” or Gaussian behavior • This example is nicely normalized Next Steps • After normalization has been completed it is a good idea to look at your data a little further to identify outliers or noise that could/should be removed Quality Control • Dealing with outliers – Detected mainly by visual inspection – May be corrected by normalization – May be excluded • Noise reduction – More of a concern for spectral bins/ peak lists – Usually improves downstream results Visual Inspection • What does an outlier look like? Finding outliers via PCA Finding outliers via Heatmap Outlier Removal (Data Editor) Noise Reduction (Data Filtering) Noise Reduction (cont.) • Characteristics of noise & uninformative features – Low intensities – Low variances (default) Data Reduction and Statistical Analysis Common Tasks • To identify important features • To detect interesting patterns • To assess difference between the phenotypes • To facilitate classification or prediction • We will look at ANOVA, Multivariate Analysis (PCA, PLS-DA) and Clustering ANOVA • Looking at 4 different dairy cow populations – 0% grain in diet – 15% grain in diet – 30% grain in diet – 45% grain in diet • Try to identify those metabolites that are different between all groups or just between 0% and everything else ANOVA Click this to view the table Click this spot and the 3-PP graph pops up View Individual Compounds Click this to see the uracil graphs What’s Next? • Click and compare different compounds to see which ones are most different or most similar between the 4 groups • Click on the Correlation link (under the ANOVA link) to generate a heat map that displays the pairwise compound correlations and compound clusters Overall Correlation Pattern Click this to save a high res. image High Resolution Image What’s Next? • When looking at >2 groups it is often useful to look for patterns or trends within particular metabolites • Use Pattern Hunter to find these trends Pattern Matching • Looking for compounds showing interesting patterns of change • Essentially a method to look for linear trends or periodic trends in the data • Best for data that has 3 or more groups Pattern Matching (cont.) Strong linear + correlation to grain % Strong linear - correlation to grain % Multivariate Analysis • Use PCA option to view the separation (if any) in the 4 groups • Look at the 2D PCA Score Plot – 2 most significant principal components • Look at the 2D PCA Loading Plot • Look at the PCA Plot in 3D – 3 most significant principal components • Options for viewing are located in the top tabs PCA Scores Plot PCA Loading Plot Compounds most responsible for separation Click on a point to view 3D Score Plot Drag to rotate Mouse over to see sample names 55 Multivariate Analysis • Use PLS-DA option to view the separation of the 4 (labeled) groups • PLS-DA “rotates” the PCA axes to maximize separation • Look at the 2D PLS Scores Plot • Look at the Q2 and R2 Values (Cross Validation) • Use the VIP plot to ID important metabolites (VIP > 1.2) PLS-DA Score Plot Evaluation of PLS-DA Model • PLS-DA Model evaluated by cross validation of Q2 and R2 • Using too many components can over-fit • 3 component model seems to be a good compromise here • Good R2/Q2 (>0.7) Important Compounds Model Validation Note, permutation is computationally intensive. It is not performed by default. Users need to set the permutation number and press the submit button Hierarchical Clustering (Heat Maps) • An alternative way of viewing or clustering multivariate data • Allows one to look at the behavior of individual metabolites • Can ask questions such as: which compounds have a low concentration in group 0, 15 but increase in the group 35 and 45? or which compound is the only one significantly increased in group 45? Heatmap Visualization Note that the Heatmap is not being clustered on Rows. It is ordered by the class labels Heatmap Visualization (cont.) What’s Next? • Most of the multivariate analysis is now done • MetaboAnalyst has been keeping track of the plots or graphs you have generated • Now its time to generate a printed report that summarizes what you’ve done and what you’ve found Download Results Analysis Report Select a Module (Enrichment Analysis) Metabolite Set Enrichment Analysis (MSEA) http://www.msea.ca Now part of Metaboanalyst • Designed to handle lists of metabolites (with or without concentration data) • Modeled after Gene Set Enrichment Analysis (GSEA) • Supports over representation analysis (ORA), single sample profiling (SSP) and quantitative enrichment analysis (QEA) • Contains a library of 6300 pre-defined metabolite sets including 85 pathway sets & 850 disease sets Enrichment Analysis • Purpose: To test if there are biologically meaningful groups of metabolites that are significantly enriched in your data • Biological meaningful in terms of: – Pathways – Disease – Localization • Currently, MSEA only supports human metabolomic data MSEA • Accepts 3 kinds of input files – list of metabolite names only (ORA – over representation analysis) – list of metabolite names + concentration data from a single sample (SSP – single sample profiling) – a concentration table with a list of metabolite names + concentrations for multiple samples/patients (QEA – quantitative enrichment analysis) The MSEA Approach ORA SSP Over Representation Analysis Single Sample Profiling Compound concentrations Compound concentrations ORA input For MSEA Quantitative Enrichment Analysis Compound concentrations Compare to normal references Compound selection (t-tests, clustering) Important compound lists QEA Abnormal compounds Assess metabolite sets directly Find enriched biological themes Metabolite set libraries Biological interpretation 73 Data Set Selected • Here we are using a collection of metabolites identified by NMR (compound list + concentrations) from the urine from 77 lung and colon cancer patients, some of whom were suffering from cachexia (muscle wasting) Start with a Compound List for ORA Upload Compound List Normally GSEA would require a list of all known genes for the given platform. Here we just use the list of metabolites found in KEGG. ORA is a “weak” analysis in MSEA Perform Compound Name Standardization Name Standardization (cont.) Select a Metabolite Set Library Result Result (cont.) Click on details to see more The Matched Metabolite Set Click on SMPDB to see more information Phenylalanine and Tyrosine Metabolism in SMPDB Single Sample Profiling (SSP) (Basically used by a physician to analyze a patient) Concentration Comparison Concentration Comparison (cont.) Quantitative Enrichment Analysis (QEA) Result Click on details to see more The Matched Metabolite Set Select a Module (Pathway Analysis) Pathway Analysis • Purpose: to extend and enhance metabolite set enrichment analysis for pathways by – Considering pathway structures – Supporting pathway visualization • Currently supports analysis for 21 diverse (model) organisms such as humans, mouse, drosophila, arabadopsis, E. coli, yeast, etc. (KEGG pathways only) Data Set Selected • Here we are using a collection of metabolites identified by NMR (compound list + concentrations) from the urine from 77 lung and colon cancer patients, some of whom were suffering from cachexia (muscle wasting) Pathway Analysis Module Data Upload Perform Data Normalization Select Pathway Libraries Perform Network Topology Analysis Pathway Position Matters Which positions are important? Hubs Nodes that are highly connected (red ones) Bottlenecks Nodes on many shortest paths between other nodes (blue ones) Graph theory Degree centrality Betweenness centrality Junker et al. BMC Bioinformatics 2006 98 Which Node is More Important? High degree centrality High betweenness centrality Pathway Visualization Pathway Visualization (cont.) Pathway Impact • Incorporates parameters such as the log fold-change of the DE metabolites, the statistical significance of the set of pathway genes and the topology of the signaling pathway • Combines the pathway topology with the over-representation evidence Result Select a Module (Biomarker Analysis) Biomarker Analysis • Purpose is to find biomarkers using ROC (receiver operator characteristic) curves with high sensitivity and specificity • Maximize AUC under ROC curve while minimizing the number of metabolites used in the biomarker panel • 3 different modules (univariate – single marker at a time, multivariate – many combinations of biomarkers, manual – user choice) Select Test Data Set 1 Click Here Click Here Data Set Selected • 90 patients (expectant mothers) at 3 months pregnancy • Serum samples • 45 patients went on to develop preeclampsia at 6-7 months • 45 patients had normal pregancies • Trying to find biomarkers for predicting early pre-eclampsia Perform Data Integrity Check Click Here Perform Log Normalization Click Here Check That It’s Normally Distributed before Click Here after Select Multivariate Option Click Here View ROC Curve Choose a Model (95% conf.) Select model 95% Confidence Interval Select Sig. Features Tab Click Here View VIP Plot Select a Module (Power Analysis) Statistical Power • Statistical power is the ability of a test to detect an effect, if the effect actually exists – A power of 0.8 in a clinical trial means that the study has a 80% chance of ending up with a statistically significant treatment effect if there really was an important difference between treatments. • To answer research questions: – How powerful is my study? – How many samples do I need to have for what I want to get from the study? Statistical Power (cont.) • The statistical power of a test depends: 1. Sample size, 2. Significance criterion (alpha) 3. Effect size Increase power • Effect size • Sample size Decrease Power • Significance criterion The Approach • How do we get these values? – Effect size can be estimated from a pilot data; – Significance criteria • Single metabolite - p value cutoff (i.e. 0.05, 0.01) • Metabolomics data – FDR (i.e. 0.1) – Sample size is our interest – Power value is our interest • You need to upload a pilot data, and set the criteria, MetaboAnalyst will compute a power vs. sample size curve by computing power values for a range of sample sizes [3, 1000] Power vs. Sample size At least 60 samples/group will needed to get a power of 0.8 Not Everything Was Covered • • • • • Clustering (K-means, SOM) Classification (SVM, randomForests) Time-series data analysis Two factor data analysis Integrative pathway analysis (gene and metabolite) Time Series Analysis in MetaboAnalyst 123 Integrative Pathway Analysis